Oxford AHSN

Oxford AHSN: Your link to NHS and academia for healthcare, innovation and wealth. OAHSN serves a population of 3.3 million in Thames Valley and Bedford, a region with strengths in drug, device and medical technology discovery and development.  The NHS and academia are eager to partner with life science businesses to drive forwards medical innovation to improve patient care and create wealth.

OAHSN is taking this opportunity to grow our Network, to develop our activities in life sciences, to listen to what investors and industry need from the NHS, and to showcase clinical innovations across the Network.

UK Trade and Investment

UK Trade & Investment is the government department that helps UK-based companies succeed in the global economy. We also help overseas companies bring their high quality investment to the UK's dynamic economy - acknowledged as Europe's best place from which to succeed in global business. UK Trade & Investment offers expertise and contacts through its extensive network of specialists in the UK, and in British embassies and other diplomatic offices around the world. For more information please visit www.ukti.gov.uk

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com

Merrill Datasite

Merrill DataSite virtual data room (VDR) offers a secure and highly efficient method to help life sciences companies manage their development cycle and protect their hard-earned intellectual property. Collaboration is key as life sciences companies work with a variety of partners within mission-critical initiatives such as fundraising, research and development, asset sales, licensing and alliance management.

Merrill DataSite maximizes this information sharing process by enhancing the ability to share data, maintaining security and keeping up with compliance standards within the ever-changing regulatory environment. Merrill DataSite provides the best in class VDR solution so companies can avoid the risks of traditional paper data rooms and unsecure electronic sharing methods such as email and FTP sites.

With over 10 years of experience handling 550 million pages of information, Merrill DataSite helps businesses maximize their intellectual property strategy, position themselves for growth, elevate their ability to collaborate and aid in staying current with document accountability obligations.

HealthTIES

The HealthTIES Consortium has been created to promote innovation in healthcare technology and is backed by the European Union. Four top European regions in biosciences, med-tech and health entrepreneurship have joined forces: Medical Delta, Biocat, Life Sciences Zurich and Oxford and Thames Valley, with a mentoring region, Ëszak-Alföld.

HealthTIES has an innovative way of working and is focused on the interactions between major disease areas and technology platforms. One of our main concerns is to speed up the transfer from science to market or, in other words, from idea to product. And, in this sense, we foster the connections between the Triple Helix: academia, industry and government.

ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON's mission is to accelerate the development of drugs that save lives and improve the quality of life. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 79 locations in 37 countries and has approximately 10,045 employees. Further information is available at www.iconplc.com.

Manches

Manches provides legal solutions across the entire life sciences industry from growing biotechnology companies and spin-outs to major PLCs.

We advise on commercial agreements, transactions, IP strategy, employment, venture arrangements, exploitation and corporate support.

Our legal expertise, from qualified scientists, helps to make new developments in biotechnology thrive.

www.manches.com

Milton Park

Located in the heart of the Oxfordshire bio-cluster and in one the UK's new Enterprise Zones, Milton Park is home to nearly 200 businesses who collectively employ over 6,500 people. The concentration and diversity of science companies at Milton Park make it a genuine centre of excellence for research and development.

Milton Park has been a major sponsor of Oxfordshire Bioscience Network for over 5 years and is pleased to be involved with BioTrinity 2013.
For more information please visit our website www.miltonpark.co.uk or drop in and meet our team on stand number 20 at BioTrinity.

Shire

Shire enables people with life-altering conditions to lead better lives.

Shire's business is built on partnerships. We understand that partners are crucial to continued success in fulfilling our mission to help patients. We seek innovative approaches to treating symptomatic diseases and improving outcomes. Across our Specialty Pharma, Human Genetic Therapies and Regenerative Medicine businesses, we welcome new technologies that have the potential to make a significant difference to patients – by diagnosing and treating their condition directly, or applying new approaches to support and optimize treatment effect. Partner with us in our main business focus areas: Behavioural Health, Gastrointestinal Health, Haematology, Neurology, Orphan Diseases, Regenerative Medicine.

Our corporate venture fund, Strategic Investment Group (SIG) is a strategic equity investor in early stage biotechnology companies with novel technologies aligned to our therapy area focus. An important element of Shire’s growth is through valued collaborations; we know that our partners' success is our success.

MSD

MSD is a global health care leader, committed to improving health and well-being around the world. MSD discovers, develops, manufactures, and markets vaccines, medicines, and consumer and animal health products designed to help save and improve lives.

The merger with Schering-Plough in 2009 greatly expanded our company's product offerings and created an innovative pharmaceutical, vaccine and biologics product line. Today's MSD offers therapies for the treatment of cardiovascular disease, high blood pressure, elevated cholesterol levels, diabetes, cancer, benign prostatic hypertrophy, asthma and allergies, arthritis, pain, migraine, glaucoma, osteoporosis, women's health, infectious diseases (antibiotic, antifungal, and antiviral agents), vaccines to prevent childhood diseases, human papilloma virus, rotavirus, shingles, and hepatitis A, B and C.

RSSL

RSSL is an independent global leader at the forefront of scientific analysis, consultancy and training, serving a range of sectors including pharmaceuticals/biopharmaceuticals and healthcare.

We provide a comprehensive range of services covering pre-clinical development to finished product, including: structural characterisation, pharmacopoeial testing, method development, stability storage management, microbiology, contamination identification, trouble shooting and training.

RSSL's support to the biopharmaceutical sector covers all aspects of the EMA regulatory guidelines for safety, quality and efficacy and are GMP compliant where appropriate, with expertise including peptide mapping/sequencing, detection of post-translational modifications, N-linked glycosylation profiling and monosaccharide analysis.

SRG

SRG is the UK's largest and Europe's third largest resourcing company dedicated to the supply of scientific, clinical, technical and engineering professionals across the scientific based industries. Our award winning integrated approach covers temporary and permanent recruitment, cutting edge managed service solutions. Our dedicated CRO, Synergy, provides cost-effective and scalable contract clinical research and scientific services. Our clinical biometric services focus purely on the management and reporting of clinical research data, whilst our on-site Functional Service Provision spans sensory panels through to stability testing for regulatory compliance and laboratory stewarding.

Takeda

World Courier

Incorporated in 1969 World Courier is the largest and most experienced specialty courier with a network of over 152 company-owned offices, all ISO certified and GxP compliant.  World Courier has set the benchmark for Bio-Pharmaceutical, time-sensitive transportation and is the acknowledged leader in delivering customized temperature-controlled solutions to the international bio-pharmaceutical industry.  With in-house scientists to understand your needs World Courier can recommend, supply and replenish packaging and refrigerants to ensure the integrity of your temperature-controlled shipments.  Documentation and regulatory requirements are managed to ensure your shipment complies with local requirements. We are dangerous-goods, Dry-Ice, liquid-Nitrogen and controlled-substance specialists.

Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realise the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. For more information, visit www.amgen.co.uk

Ardington Archives

Ernst & Young

James Cowper

James Cowper is one of the leading firms of accountants and business advisers in London, the Thames Valley and South of England.

We understand the issues businesses face from early-stage spin-outs to growth and exit and have a specialism working with technology-based businesses and those operating in the life-science sector. We also contribute to the industry through regularly working UK research councils and tech transfer units of a number of research institutions, as well as sponsorships to regular speaking slots/lectures at conferences, to students and academics.

Our firm has significant international experience and expertise acting for over 200 international groups as clients. We are members within the Kreston network of accountants which is ranked 13th globally. www.jamescowper.co.uk.

JA Kemp

J A Kemp is the one of the largest UK and European Patent and Trade Mark Attorney firms, with over 50 science and technology graduates including at least 25 PhDs. No area of science or technology is outside the firm's scope. J A Kemp is renowned for its long experience of prosecuting applications in Europe and worldwide, and for its track record of success in oppositions and appeals. With offices in London, Oxford and Munich, J A Kemp’s client base ranges from major multi-national groups to small start-up companies at the leading edge of their fields and prestigious universities.

OUH/Oxford University

The research expertise of the University of Oxford and the clinical skills of Oxford University Hospitals NHS Trust have been brought together within the Oxford Biomedical Research Centre (BRC). The BRC is a partnership which supports translational research and innovation from the bench to the bedside, and it is funded by the National Institute for Health Research. It aims to directly benefit patients and improve health care delivery.

With renowned international scientists and clinicians working on basic science through to patient trials and clinical practice, Oxford is consistently at the forefront of innovative and life-saving science. We understand the value of collaboration and welcome the opportunity to build partnerships with industry, academia, and not-for-profit organisations.

Oval Insurance

Swiss Biotech Association

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, and specialty chemicals. Members are companies concerned with different aspects of modern biotechnology such as R&D, production, marketing and sales, finance, services and consulting. SBA provides the networking platform for cluster organisations, academic and federal institutions. Founded in March 1998, the Association represents more than 80% of the sector.

AbbVie

Abingworth

Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.

Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of 19 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.

Sponsor of Gala Dinner Drinks Reception:
Charles Russell LLP

Charles Russell provides legal advice to businesses, institutions and private individuals in the UK and internationally.  We have a special interest in Healthcare and Life Science. Our team handles advisory, commercial and dispute resolution work of all types. We seek to maximise commercial returns as well as limiting potential liabilities, which can be considerable, more especially in the US. Our clients range from big pharma and medical device companies to start-ups, covering research, development, licensing (in all forms), manufacture and distribution as well as providers of screening, contract research and other services

Citigate Dewe Rogerson

PharmaVentures